Skip to main content
Novonesis AS logo

Novonesis AS — Investor Relations & Filings

Ticker · NSIS ISIN · DK0060336014 LEI · 529900T6WNZXD2R3JW38 CO Manufacturing
Open in API
Filings indexed 2,308 across all filing types
Latest filing 2022-05-16 Transaction in Own Shar…
Country DK Denmark
Listing CO NSIS

About Novonesis AS

https://www.novozymes.com/en

Novonesis is a global biosolutions company formed through the combination of Novozymes and Chr. Hansen. The company develops and produces a broad portfolio of biological solutions, including industrial enzymes, functional proteins, and microorganisms such as cultures, probiotics, and yeast. Its products are utilized in over 30 industries to improve efficiency, sustainability, and product quality. Key markets include food and beverage, where solutions enhance nutrition and reduce waste; human and animal health; agriculture, promoting higher crop yields and animal welfare; and household care, for more effective cleaning. Novonesis applies biotechnological principles to address global challenges in production and consumption, aiming to create more sustainable systems and products.

Recent filings

Filing Released Lang Actions
Transactions under Novozymes’ stock buyback program
Transaction in Own Shares Classification · 95% confidence The document is a short announcement (529 characters) regarding a stock buyback program. It explicitly states 'Please read the full announcement in the attached PDF' and provides a link to the attachment. According to the 'Menu vs Meal' rule, this is an announcement of a report/transaction rather than the transaction report itself, and it specifically relates to the company buying back its own shares.
2022-05-16 English
Transaction in Own Shares 2022
Transaction in Own Shares Classification · 99% confidence The document explicitly details transactions made under Novozymes' 'stock buyback program'. It provides accumulated figures, daily transaction details (number of shares, average price, value), and regulatory references related to these transactions (Market Abuse Regulation). This content directly relates to the company purchasing its own shares, which corresponds precisely to the definition of 'Transaction in Own Shares' (POS). It is not a general regulatory filing (RNS), an earnings release (ER), or a comprehensive financial report (10-K/IR).
2022-05-09 English
Transactions under Novozymes’ stock buyback program
Transaction in Own Shares Classification · 98% confidence The document is a short announcement regarding a stock buyback program. It explicitly states 'Please read the full announcement in the attached PDF' and provides a link to the attachment. According to the 'Menu vs Meal' rule, since this is a short announcement directing the reader to an attached report, it is classified as a Report Publication Announcement (RPA).
2022-05-09 English
Transaction in Own Shares 2022
Transaction in Own Shares Classification · 100% confidence The document text is extremely short (529 characters) and explicitly states, "Please read the full announcement in the attached PDF" and provides a link to a document titled "Transactions under Novozymes’s stock buyback program". This structure indicates that the current document is an announcement about a transaction involving the company's own shares (a buyback program), rather than the detailed report itself. According to the 'MENU VS MEAL' rule, a short announcement pointing to a full document should be classified as a Report Publication Announcement (RPA) or a specific transaction type. Since the subject is a stock buyback, the most specific category is 'Transaction in Own Shares' (POS). However, given the explicit instruction to use RPA if it's just an announcement pointing to the main document, and POS is for the report of the transaction itself, I must weigh the specificity. The content is clearly about a share repurchase program, which maps directly to POS. Since the document is an announcement *of* the transaction details (which are in the PDF), it could also be RPA. Given the highly specific nature of POS ('Report of the company buying back or selling its own shares'), and the fact that this announcement is the primary disclosure mechanism for the buyback activity, POS is the most accurate classification for the *subject matter*, even if it's a brief notice. If the subject matter was not covered by a specific code, RPA would be used. Since POS exists for buybacks, I select POS.
2022-05-02 English
Transactions under Novozymes’ stock buyback program
Transaction in Own Shares Classification · 100% confidence The document is a formal company announcement (No. 15) detailing the specific transactions made under Novozymes' stock buyback program. It provides a summary of shares purchased, the total transaction value, and an extensive appendix of individual trade data (date, volume, price, venue). This falls directly under the definition of 'Transaction in Own Shares' (POS), which covers reports of a company buying back its own shares.
2022-05-02 English
Report Publication Announcement 2022
Report Publication Announcement Classification · 99% confidence The document text is extremely short (470 characters) and explicitly states 'Interim report for Q1 2022' but immediately directs the user to 'Please read the full announcement in PDF' and provides an attachment link. This structure—a brief announcement pointing to the full document—fits the definition of a Report Publication Announcement (RPA) rather than the comprehensive Interim Report (IR) itself, adhering to the 'MENU VS MEAL' rule.
2022-04-26 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.